Evaluation of Antigen-Specific IgM and IgG Production during an Peripheral Blood Mononuclear Cell Culture Assay.

Yoshiko Matsuda, Ryoichi Imamura, Shiro Takahara
Author Information
  1. Yoshiko Matsuda: Department of Advanced Technology for Transplantation, Graduate School of Medicine, Osaka University, Osaka, Japan.
  2. Ryoichi Imamura: Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  3. Shiro Takahara: Department of Advanced Technology for Transplantation, Graduate School of Medicine, Osaka University, Osaka, Japan.

Abstract

The recent attention given to diseases associated with memory B-cell (mBC)-produced antibodies (Abs) suggests the need for a similar assay to evaluate the functions of mBCs. Here, we cultured peripheral blood mononuclear cells (PBMCs) with the intent to collect mBC-derived Abs and maintain their cell-cell contact-dependent interactions with helper T-cells. PBMCs were cultured with interleukin (IL)-21, CpG-oligodeoxynucleotides (ODN), phorbol myristate acetate (PMA), and phytohemagglutinin/leucoagglutinin (PHA-L) in 24-well flat-bottom plates (5 × 10 cells/well). A culture supernatant analysis of PBMCs from healthy donors ( = 10) indicated that antigen-specific IgM Ab levels in a PBMC culture supernatant might be better able to demonstrate the antigen sensitization status in a smaller peripheral blood sample, compared to IgG because Epstein-Barr virus-specific IgM mBCs circulate peripherally at a significantly higher frequency once antiviral humoral immunity has stabilized. Thus, our assay demonstrated the potential significance of antigen-specific IgM Ab production in the culture supernatants. Furthermore, an analysis of cultured PBMCs from allograft kidney recipients ( = 16) sensitized with donor-specific human leukocyte antigen (HLA)-specific Abs (DSAs) showed that IgM-type HLA-specific Abs were detected mainly from the culture supernatants from PBMCs of patients with stable graft function, whereas IgG isotype HLA Abs were detectable only from patients with biopsy-proven antibody-mediated rejection. In other words, these IgG isotype Abs also represented an activated humoral immune response . Additionally, IgM- and IgG-expressing mBCs from healthy donors ( = 5) were cultured with IL-21, CpG-ODN, and a supernatant produced by stimulating CD19 B-cell-depleted PBMCs with PHA-L and PMA in 24-well flat-bottom plates (1 × 10 cells/well), and the resulting analysis provided some information regarding the biological processes of IgG and IgM mBCs in peripheral blood. Taken together, our findings suggest that antigen-specific Ab subtype analyses of supernatants from cultured PBMCs might more effectively and accurately reflect a patient's Ab-associated pathological condition vs. than serum IgG and IgM levels.

Keywords

References

  1. Genes Dev. 2004 Jan 1;18(1):1-11 [PMID: 14724175]
  2. J Am Soc Nephrol. 2015 Jul;26(7):1489-502 [PMID: 25804279]
  3. Transplantation. 2001 Apr 27;71(8):1106-12 [PMID: 11374411]
  4. J Immunol. 2012 Apr 1;188(7):3542-50 [PMID: 22345652]
  5. Semin Immunol. 2006 Oct;18(5):263-75 [PMID: 16914324]
  6. Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12192-7 [PMID: 20547847]
  7. Scand J Immunol. 1999 May;49(5):523-32 [PMID: 10320646]
  8. Nat Rev Immunol. 2015 Mar;15(3):137-48 [PMID: 25656706]
  9. Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):520-6 [PMID: 18978466]
  10. Semin Immunol. 2005 Dec;17(6):442-51 [PMID: 16263308]
  11. Blood. 2007 Feb 15;109(4):1611-9 [PMID: 17032927]
  12. Eur J Immunol. 1981 Aug;11(8):657-61 [PMID: 6456149]
  13. Curr Top Microbiol Immunol. 2006;311:59-83 [PMID: 17048705]
  14. J Immunol. 2007 Jul 1;179(1):13-9 [PMID: 17579014]
  15. Front Immunol. 2011 Dec 26;2:81 [PMID: 22566870]
  16. Curr Opin Immunol. 2006 Jun;18(3):278-85 [PMID: 16516453]
  17. Am J Transplant. 2009 Nov;9(11):2520-31 [PMID: 19843030]
  18. J Leukoc Biol. 2000 Jan;67(1):2-17 [PMID: 10647992]
  19. Kidney Int. 2015 Oct;88(4):874-87 [PMID: 26176829]
  20. Am J Pathol. 2007 Sep;171(3):715-27 [PMID: 17640961]
  21. Nat Rev Immunol. 2006 Oct;6(10):741-50 [PMID: 16977339]
  22. Immunol Lett. 2013 May;152(2):114-20 [PMID: 23660557]
  23. Immunol Rev. 2011 Nov;244(1):115-33 [PMID: 22017435]
  24. J Exp Med. 2003 Jun 16;197(12):1677-87 [PMID: 12796466]
  25. Hum Immunol. 2016 Nov;77(11):1048-1054 [PMID: 26902993]
  26. Am J Med. 2000 Nov;109(7):531-7 [PMID: 11063953]
  27. J Exp Med. 1998 Apr 20;187(8):1325-34 [PMID: 9547343]
  28. J Immunol. 2005 Jul 15;175(2):909-16 [PMID: 16002689]
  29. J Immunol. 2007 Dec 15;179(12):8180-90 [PMID: 18056361]
  30. Nat Rev Immunol. 2002 May;2(5):323-35 [PMID: 12033738]
  31. J Immunol. 2009 Dec 15;183(12):7661-71 [PMID: 19933871]
  32. Immunol Rev. 1997 Apr;156:53-66 [PMID: 9176699]
  33. Immunol Cell Biol. 2016 Sep;94(8):774-86 [PMID: 27101923]
  34. Cell Immunol. 2015 Jun;295(2):127-36 [PMID: 25880104]
  35. Transpl Immunol. 1998 Jun;6(2):101-6 [PMID: 9777698]
  36. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2485-90 [PMID: 22308386]
  37. Am J Transplant. 2008 Feb;8(2):324-31 [PMID: 18162086]
  38. Am J Transplant. 2012 Jun;12(6):1469-78 [PMID: 22390272]
  39. Immunity. 1998 Mar;8(3):363-72 [PMID: 9529153]
  40. Annu Rev Immunol. 2005;23:487-513 [PMID: 15771579]
  41. Immunity. 2006 Oct;25(4):545-57 [PMID: 17000121]
  42. Adv Immunol. 1974;18:67-132 [PMID: 4151339]
  43. Transplantation. 2014 Feb 27;97(4):405-12 [PMID: 24445924]
  44. J Exp Med. 1995 Jun 1;181(6):2077-84 [PMID: 7539038]
  45. Am Fam Physician. 1994 Mar;49(4):879-88 [PMID: 8116521]
  46. Nature. 1998 Jun 4;393(6684):480-3 [PMID: 9624005]
  47. Blood. 2009 Dec 10;114(25):5173-81 [PMID: 19846886]
  48. Histol Histopathol. 2000 Apr;15(2):573-6 [PMID: 10809378]
  49. Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15 [PMID: 23684423]
  50. J Immunol. 2008 Aug 1;181(3):1767-79 [PMID: 18641314]
  51. J Immunol. 2004 Oct 1;173(7):4479-91 [PMID: 15383579]
  52. Blood. 2003 Jun 1;101(11):4464-71 [PMID: 12531790]
  53. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E546-55 [PMID: 25624468]
  54. Trends Immunol. 2011 Dec;32(12):595-602 [PMID: 22001488]
  55. Crit Rev Immunol. 2012;32(4):287-305 [PMID: 23237506]
  56. Circ Res. 2005 Jun 24;96(12):1248-56 [PMID: 15905460]
  57. J Infect Dis. 2007 Dec 15;196(12):1749-53 [PMID: 18190254]
  58. Am J Transplant. 2012 Feb;12(2):388-99 [PMID: 22081892]
  59. Hum Immunol. 2009 Jan;70(1):29-34 [PMID: 19026703]

Word Cloud

Created with Highcharts 10.0.0PBMCsIgMIgGAbsculturedmBCsculturememoryassayperipheralbloodcellssupernatantanalysisantigen-specificAbsupernatantsPMAPHA-L24-wellflat-bottomplateshealthydonorslevelsmightantigenhumoralHLApatientsisotypeBrecentattentiongivendiseasesassociatedB-cellmBC-producedantibodiessuggestsneedsimilarevaluatefunctionsmononuclearintentcollectmBC-derivedmaintaincell-cellcontact-dependentinteractionshelperT-cellsinterleukinIL-21CpG-oligodeoxynucleotidesODNphorbolmyristateacetatephytohemagglutinin/leucoagglutinin5 × 10 cells/well = 10indicatedPBMCbetterabledemonstratesensitizationstatussmallersamplecomparedEpstein-Barrvirus-specificcirculateperipherallysignificantlyhigherfrequencyantiviralimmunitystabilizedThusdemonstratedpotentialsignificanceproductionFurthermoreallograftkidneyrecipients = 16sensitizeddonor-specifichumanleukocyte-specificDSAsshowedIgM-typeHLA-specificdetectedmainlystablegraftfunctionwhereasdetectablebiopsy-provenantibody-mediatedrejectionwordsalsorepresentedactivatedimmuneresponseAdditionallyIgM-IgG-expressing = 5IL-21CpG-ODNproducedstimulatingCD19B-cell-depleted1 × 10 cells/wellresultingprovidedinformationregardingbiologicalprocessesTakentogetherfindingssuggestsubtypeanalyseseffectivelyaccuratelyreflectpatient'sAb-associatedpathologicalconditionvsserumEvaluationAntigen-SpecificProductionPeripheralBloodMononuclearCellCultureAssayantibody-associateddiseasegerminalcentersvitro

Similar Articles

Cited By